SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-24-000116
Filing Date
2024-07-31
Accepted
2024-07-31 17:00:44
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20240630.htm   iXBRL 10-Q 1328081
2 EX-31.1 exhibit311q22024.htm EX-31.1 10594
3 EX-31.2 exhibit312q22024.htm EX-31.2 10581
4 EX-32.1 exhibit321q22024.htm EX-32.1 7698
  Complete submission text file 0001570562-24-000116.txt   6890478

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20240630.xsd EX-101.SCH 46680
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20240630_cal.xml EX-101.CAL 70908
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20240630_def.xml EX-101.DEF 256051
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20240630_lab.xml EX-101.LAB 664571
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20240630_pre.xml EX-101.PRE 440861
67 EXTRACTED XBRL INSTANCE DOCUMENT eols-20240630_htm.xml XML 776690
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 241162820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)